Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Yes, carrying excess weight and having fatty liver disease (MASLD) are among the most common reasons for a mildly to moderately elevated ALT, since fat buildup inflames liver cells and leaks the enzyme into the blood. However, ALT levels can also rise from alcohol use, certain medications and supplements, viral hepatitis, thyroid or muscle conditions, and even strenuous exercise before the draw, so the number alone does not confirm the cause. There are several important factors and warning signs to consider, including how high the ALT is, the ALT-to-AST ratio, and which follow-up tests are usually recommended: see below to understand more.
Because a high ALT can reflect anything from reversible fat accumulation to progressive liver scarring, understanding your own risk pattern matters before you wait months for a repeat test. A free, instant, online symptom check can help you organize your symptoms, weight and lifestyle history, and medication list into a clear picture, then point you toward the right next steps and the right type of clinician to see.
Last reviewed for medical accuracy: 09/13/2026
An ALT blood test measures levels of alanine aminotransferase (ALT), an enzyme found mainly in the liver. When liver cells are injured or inflamed, ALT can leak into the bloodstream, leading to an elevated result. Many factors can affect ALT levels; two common contributors are excess weight and fatty liver disease. Below, we’ll explore how these conditions influence ALT, what the results can mean, and steps you can take to protect your liver.
In most cases of NAFLD, ALT stays mildly to moderately elevated. If your ALT is very high, your healthcare provider will look for other causes.
If you have a high ALT, your doctor will review your medical history, medication list, alcohol use, and may order additional tests (imaging, antibody panels) to pinpoint the cause.
Adopt a Balanced Diet
Lose Weight Safely
Stay Active
Limit Alcohol Intake
Review Medications and Supplements
Monitor Your Health
If you experience any of the following, please speak to a doctor promptly:
For a quick, confidential review of your symptoms, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
This overview is based on credible medical guidelines and research. If you have any concerns—especially those that could indicate a life-threatening issue—please speak to a doctor. Your healthcare provider can offer personalized advice and, if needed, further testing or treatment.
(References)
* Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013 Apr;94(2):93-103. doi: 10.1111/iep.12008. Epub 2013 Jan 11. PMID: 23305254; PMCID: PMC3607137.
* Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. PMID: 26057287.
* Mohamed RZ, Jalaludin MY, Anuar Zaini A. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. J Pediatr Endocrinol Metab. 2020 Feb 25;33(2):247-253. doi: 10.1515/jpem-2019-0403. PMID: 31926095.
* Mitsinikos T, Mrowczynski-Hernandez P, Kohli R. Pediatric Nonalcoholic Fatty Liver Disease. Pediatr Clin North Am. 2021 Dec;68(6):1309-1320. doi: 10.1016/j.pcl.2021.07.013. PMID: 34736591.
* Silva MBBE, Tustumi F, Dantas ACB, Miranda BCJ, Pajecki D, DE-Cleva R, Santo MA, Nahas SC. OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES. Arq Bras Cir Dig. 2022;34(4):e1626. doi: 10.1590/0102-672020210002e1626. Epub 2022 Jan 31. PMID: 35107488; PMCID: PMC8846460.
* Liba H, Belahsen R. Models to predict non-alcoholic fatty liver disease linked to obesity in Morocco. Rocz Panstw Zakl Hig. 2022;73(3):325-332. doi: 10.32394/rpzh.2022.0223. PMID: 36169376.
* Altalebi RR, Al-Hussaniy HA, Al-Tameemi ZS, Al-Zobaidy MA, Albu-Rghaif AH, Alkuraishy HM, Hedeab GM, Azam F, Al-Samydai AM, Naji MA. Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes. J Med Life. 2023 Jan;16(1):42-47. doi: 10.25122/jml-2022-0091. PMID: 36873135; PMCID: PMC9979179.
* Del Bo' C, Perna S, Allehdan S, Rafique A, Saad S, AlGhareeb F, Rondanelli M, Tayyem RF, Marino M, Martini D, Riso P. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials. Nutrients. 2023 May 9;15(10). doi: 10.3390/nu15102250. Epub 2023 May 9. PMID: 37242133; PMCID: PMC10222807.
* Agrinier AL, Morissette A, Daoust L, Gignac T, Marois J, Varin TV, Pilon G, Larose É, Gagnon C, Desjardins Y, Anhê FF, Carreau AM, Vohl MC, Marette A. Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial. Cell Rep Med. 2024 Aug 20;5(8):101682. doi: 10.1016/j.xcrm.2024.101682. PMID: 39168095; PMCID: PMC11384942.
* Bhagat N, De A, Duseja A, C P G, Kumar M, Mehta M, Taneja S, Sahni N, Singh V. Saroglitazar for non-obese metabolic-dysfunction associated steatotic liver disease (MASLD): An open-label randomised controlled trial. Indian J Med Res. 2026 Apr;163(4):477-485. doi: 10.25259/IJMR_2953_2025. PMID: 42165726; PMCID: PMC13224251.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.